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Participants (230) from Germany and 20 laboratories in 11 European countries took part in a newly designed cerebrospinal fluid (CSF) survey distributed by INSTAND. Conventional proficiency testing for albumin, lgG, IgA, and 1gM in CSF and serum, for total protein in CSF, and for oligoclonal lgG in CSF and serum was combined with evaluation and interpretation of CSF/serum quotients in quotient diagrams. The correct detection of a blood-CSF barrier dysfunction and the pattern of intrathecal immunoglobulin synthesis was judged. The accuracy of CSF/ serum quotients and their clinically relevant interpretation was given first priority as a new concept in quality assessment.
The main result of the surveys was to confirm that CSF/serum quotients of proteins represent method-independent values approaching the quality of reference values. This finding has consequences for internal quality control of CSF analysis and for accreditation bodies. The sensitivity of the methods for quantifying IgA and 1gM in CSF and for detecting oligoclonal IgG fractions is discussed.
Indexing Terms afbumu/immurog!obullns/o1igodonaI
IgG/inLema/ However, discrimination between brain-derived and blood-derived protein fractions in CSF is possible by taking into account the individual blood-CSF barrier function/dysfunction, referring the CSF/serum quotients for IgG, IgA, and 1gM to the albumin CSF/ serum quotient of the individual patient (3, 6-9).
This approach minimizes the influence of variations in non-specific individual variables such as CSF flow rate (8,
10),
age of the patient (11, 12), and volume of CSF extracted.
The graphical presentation of the CSF and serum data in quotient diagrams is designed to benefit the clinician (3). The best discrimination function or formula for the identification of an intrathecal synthesis of immunoglobulin is still subject to discussion (13-16), but there is at least consensus (3) that a nonlinear approach is essential for discrimination between bloodderived and brain-derived concentrations of IgG, IgA, or 1gM in CSF. In the surveys the hyperbolic function (8, 9) illustrated in Fig. 1 , meanwhile shown to be the physiologically and physically correct form (8, 16), has been introduced. This diagram represents an improved evaluation graph (8) routinely used for CSF data reports in >80 German or other European neurological clinics for a clinically relevant pattern recognition (4, (17) (18) (19) (20) (21) (22) .
Materials and Methods
The CSF samples distributed for proficiency testing were taken from patients punctured for routine CSF diagnosis in the Neurologic Clinic, University of Gottingen. After the diagnostic procedures, residual CSF volumes were pooled and kept at -30#{176}C. Pools of CSF samples and serum samples from patients were cleared by filtration and stabilized by adding 0.1 g/L thimerosal (sodium salt; Sigma, Deisenhofen, Germany).
Two pairs of CSF and serum samples (0.7 mL each) for quantitative analysis for total protein, albumin, IgG, IgA, and 1gM were distributed, with a form for each CSF/serum pair. This data form contained the age of a fictitious patient and blank diagrams (see Fig. 1 (19, 21) .
pants. Besides the individual data for CSF and serum values, CSF/serum quotients had to be reported, numerically and as points in the quotient diagrams on the supplied forms (Fig. 1 ). For interpretation of the results, the following comments were proposed: normal
CSF;
blood-CSF barrier dysfunction; inflammatory process; and intrathecal synthesis of IgG, IgA, and (or) 1gM. The basis for this evaluation of immunoglobulin synthesis is given below. Age-related reference ranges for blood-CSF barrier function are listed in Table 1 . Table 2 together with a score for accuracy and the target values). The second pair of CSF samples in the same CSF survey had the following target values:0AIb = 7.3 X 10, #{176}uo = 4.8 X i0, Q1g = 2.6 X i0, 0I9M = 0.6 x 10. Given the low lgA and 1gMconcentrations in CSF (IgA = 5.7 mg/L, 1gM 0.9 mg/I), the overall performance for analysis of the second pair was worse than for the sample pair shown here.
258 CLINICAL CHEMISTRY, Vol. 41, No. 2, 1995 (Table 2 ). In addition to the graphical and numerical evaluation, the overall performance of the laboratory was summarized in the certificate of participation (Table 3) with a primary emphasis placed on clinically relevant interpretation and the accuracy of quotients (method-independent values). Second, in case of a large deviation in the quotients, the participant received a notation about the origin of the fault, whether in the absolute CSF value, the absolute serum value, or incorrect calculation.
Results
Albumin, lgG, IgA, and 1gM
The typical report sent to a single participant in the CSF survey looks like Fig. 2 and Table 2 together with a certificate of participation (Table 3 ). The data in Fig.  2 represent the CSF/serum quotients of all participants and mark the individual data of the participant (thin lines) to verify correct entry of the data and to provide an individual comparison with the other participants. Table 2 gives the relevant target values, the consensus values, and the participants' performance as the percentage deviation from the target value. If the number of successful participants was too small (e.g., 1gM in Table 2 ), or if the number of outliers was too large (>10%), no consensus value was reported.
The improvement of accuracy afforded by quotient evaluation compared with the absolute values in CSF and serum is shown with data from the single participant in Table 2 . Despite poor accuracy for absolute 1gM values in CSF and serum (-23% and -21%, respectively), the participant obtained excellent performance in the CSF/serum quotient, QIgM (+ 2%). 3) The evaluation of CSF/serum quotients is more useful than the evaluation of absolute values in scoring the quality assessment of a single laboratory.
Several important restrictions must be considered: The application of the consensus values of all participants as target values instead of the assigned values is valid only if the number of participants is large enough and if the number of outliers is small compared with the total number of participants.
For Qb and Q1 we observed an acceptable 3 to 9 outliers among 128 participants.
In contrast, QIgM (with the 1gM in CSF = 1.1 mg/L) had 26 outliers among 37 participants, which does not allow the calculation of a consensus value. The problem of detecting outliers in a nongaussian distribution is obvious for 1gM and partly obvious for IgA, whereas the distribution of the albumin and IgG quotients allows the data to be treated as a gaussian-like distribution.
In general, the worse performance for 1gM and occasionally for IgA analysis was due to an unqualified application of automated methods that were not sensitive enough for CSF analysis. The discrepancies between the QIgA consensus value and the target value in Table 2 originate from unpaired analysis of CSF and serum samples by some participants, as indicated by the larger CV for Q (20.1%) than for the absolute IgA values in CSF and serum (9.4% and 9.7%, respectively).
Total Protein in CSF
Total protein data were evaluated regardless of the methods used-dye binding; trichioroacetic acid precipitation with nephelometric or turbidimetric detection; or biuret method after preconcentration. The number of outliers decreased from 35% in survey 1990 to 7% in survey 1994. The consensus values for total protein were in excellent concordance (median difference 1.8%, n = 10 surveys) with the assigned values obtained with a nephelometric method for protein analysis in CSF (23).
Oligoclonal lgG Fractions
The performance of two surveys with similar CSF samples (four or five weak oligoclonal IgG bands in CSF from a single patient) paired with polyclonal serum (pooled from many different patients to avoid an oligoclonal pattern in serum) is summarized in Table 5 . CSF-restricted oligoclonal bands (type 2) should have been reported. The reported results (Table 5 ) support the recommendations of the consensus paper (3): Ohgoclonal banding must be detected by IEF; agarose electrophoresis is not sensitive enough. Moreover, detection with IEF on macrogels appears to be more sensitive than that on microgels (with direct silver stain of proteins). The good performance of the few participants who used immune detection after IEF on macrogels is in concordance with these recommendations (3). Some of the participants reported type 3 (oligoclonal bands in CSF with additional identical bands in CSF and serum) instead of type 2 (CSFrestricted oligoclonal bands). This partly wrong interpretation ("oligoclonal" bands in definitely polyclonal In the corresponding CSF survey the CVs from consensus of all participants were 7-15%. Overall performance of survey 1111993 (231 participants) was as follows: 60% of all participants reported accurate analytical data; 30% gave a correct clinical interpretation in addition to the accurate analytical data. Only 10% of the participants had a perfect and complete report: i.e., only 9 laboratories had a completely correct analysis and interpretation for all variables (Qb, Q1, QLA, QIgM, and oligoclonal IgG) and for all pairs of samples (high and low CSF concentration). A somewhat larger number (n = 13) of participants in a group participating in a restricted program (no IgA and 1gM) had good performance.
Consequently, one can conclude that sufficient quality in clinical neurochemistry is still restricted to a small but increasing number of expert laboratories.
Discussion and Recommendations

Accuracy in CSF Diagnosis
The main analytical problems observed in the CSF The accuracy requested by the accreditation bodies for albumin, IgG, IgA, and 1gM in blood (24) is not relevant for the absolute values of these analytes in CSF, given the more sophisticated methods needed for quantifying the very low concentrations in CSF. It makes no sense to suggest a maximal allowable deviation from the target value in serum of 3% (24) for total protein in CSF, the concentration of which is only 1% of the serum reference values.
From the latest (1994) CSF survey an allowed deviation (CV) from the consensus value of 10% would still exclude 34% of the participants.
CSF/Serum Quotients as Method-Independent Values
One of the most important results of the CSF survey was the confirmation that CSF/serum quotients can be treated as method-independent values (Table 4) . Quotient values approach the quality of reference values, usually obtained only with reference methods. For judging the accuracy of single serum proteins in CSF, referring to the accuracy of CSF/serum quotients appears to be the best approach in CSF surveys. However, this is valid only if paired CSF and serum samples from the same patient are analyzed with the same method in the same analytical run, and are referred to the same calibration curve. As shown in the results, this is one of the most prominent faults in the surveys, leading to larger CVs for the quotients compared with the CVs of the absolute values in CSF or serum of the single protein.
Target Value, Assigned Value, Consensus Value
The discussions of the international standardizing organizations led to helpful definitions (see Appendix) but left some controversies unresolved. One concerns the hierarchy between the terms "assigned value" and "target value." In this survey the target value ("Zielwert") refers to the best available value for statistical evaluation of the survey. This value can be obtained as a reference value (rarely available) or from an assigned value ("Sollwert"), which is a method-dependent value. Because for CSF diagnosis no reference methods are available, the target value in this case has to refer to assigned values originating from a consensus of few invited expert laboratories (trial) or, less expensively, from a consensus from all participants of the survey, with some restrictions.
Consensus values of all participants as target values may be acceptable for albumin and IgG, in particular for the method-independent quotients. For IgA and 1gM, however, the situation was completely different: Occasionally, the low number of successful participants (<30), the large variation among results (and nongaussian distribution), and large number of outliers did not allow calculation of participants-based consensus values that were acceptable as target values. For example, in Table 2 the consensus value was adversely affected by results from a group of participants who measured CSF and serum in different runs or with different methods. In such cases the consensus value from the three expert laboratories is a better choice for the target value (1).
Clinically Oriented Accuracy
For general quality assessment, the certificate of participation (Table 3) documents the "patient-related" true results with greatest priority: reporting the albumin quotient with reference to its age-appropriate value (Table 1 ) and the detection of intrathecally synthesized immunoglobulin in diagrams (Fig. 1) as a goal of CSF diagnosis. The integration of CSF data into a pattern with disease-related, differential diagnostic relevance has proved to be of great benefit for the neurologist (4). The absolute concentrations of a single protein in CSF and serum were of secondary value, used only to determine the source of any analytical faults.
As a training program the survey has contributed to a more general quality assessment involving proficiency testing and plausibility control by comparison of data (e.g., the albumin in CSF must be less than total protein concentration, or a QjSQb ratio in range 5 of 
